Nuveen
SANA icon

Nuveen’s Sana Biotechnology SANA Stock Holding History

Nuveen’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
369,722
+42,750
+13% +$138K ﹤0.01% 2810
2026
Q1 		$942K Buy
326,972
+1,760
+0.5% +$6.93K ﹤0.01% 2606
2025
Q4 		$1.32M Buy
325,212
+21,183
+7% +$94.9K ﹤0.01% 2473
2025
Q3 		$1.08M Hold
304,029
– – ﹤0.01% 2588
2025
Q2 		$830K Sell
304,029
-46,510
-13% -$96K ﹤0.01% 2689
2025
Q1 		$589K Hold
350,539
– – ﹤0.01% 2850
2024
Q4 		$571K Sell
350,539
-27,104
-7% -$80.8K ﹤0.01% 2936
2024
Q3 		$1.57M Sell
377,643
-64,934
-15% -$341K ﹤0.01% 2542
2024
Q2 		$2.42M Sell
442,577
-112,011
-20% -$893K ﹤0.01% 2291
2024
Q1 		$5.55M Sell
554,588
-173,446
-24% -$1.3M ﹤0.01% 1933
2023
Q4 		$2.97M Sell
728,034
-43,405
-6% -$160K ﹤0.01% 2228
2023
Q3 		$2.99M Sell
771,439
-1,346
-0.2% -$7.24K ﹤0.01% 2124
2023
Q2 		$4.61M Sell
772,785
-7,290
-0.9% -$42K ﹤0.01% 1961
2023
Q1 		$2.55M Buy
780,075
+55,450
+8% +$222K ﹤0.01% 2239
2022
Q4 		$2.86M Buy
724,625
+287,018
+66% +$1.4M ﹤0.01% 2225
2022
Q3 		$2.63M Sell
437,607
-167,900
-28% -$1.21M ﹤0.01% 2260
2022
Q2 		$3.89M Buy
605,507
+233,540
+63% +$1.49M ﹤0.01% 2113
2022
Q1 		$2.55M Buy
371,967
+117,788
+46% +$952K ﹤0.01% 2392
2021
Q4 		$4.06M Sell
254,179
-177,405
-41% -$3.42M ﹤0.01% 2235
2021
Q3 		$10.8M Buy
431,584
+128,606
+42% +$2.7M ﹤0.01% 1725
2021
Q2 		$5.96M Sell
302,978
-359,577
-54% -$8.15M ﹤0.01% 2157
2021
Q1 		$22.2M Buy
+662,555
New +$21.6M 0.01% 1241

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Nuveen's SANA Position: Q2 2026 in Review

Nuveen increased its Sana Biotechnology (SANA) stake by 13% in Q2 2026, buying an estimated $138K and bringing the position to 369,722 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2810.

Nuveen first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $22.2M in Q1 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Nuveen held 369,722 shares of Sana Biotechnology worth $1.29M as of Q2 2026.
  • Nuveen bought 42,750 Sana Biotechnology shares in Q2 2026, an estimated $138K.
  • Sana Biotechnology made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2810 holding.
  • Nuveen first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Nuveen's Sana Biotechnology position peaked at $22.2M in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.